Systemic antiviral treatment

Details Systemic antiviral treatment Systemic antiviral treatment

1989-11-02

1991-12-03

Nutter, Nathan M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

514936, 514944, 514965, 514966, 514967, 514969, 424434, 424435, 424436, 424449, A01N 3100, A61K 31045, A01J 2100

Patent

active

050701070

ABSTRACT:
Systemic antiviral treatment using a narrow class of aliphatic straight-chain saturated monohydric alcohols which have from 27 to 32 carbons in the chain in physiologically compatible compositions for injection or trans-mucus membrance introduction into humans and other mammals is disclosed.

REFERENCES:
patent: 4186211 (1980-01-01), Debat
patent: 4513008 (1985-04-01), Revici et al.
Borg et al., "Neurotrophic Effect of Naturally Occuring Long-Chain Fatty Alcohols on Cultured CNS Neurons" FEBS Letters, vol. 213, No. 2, 406-410, Mar. 1987.

Affiliated with

Also associated with

Rating

Systemic antiviral treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Systemic antiviral treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Systemic antiviral treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1697268